http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1147202-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 |
| filingDate | 1966-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1969-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1147202-A |
| titleOfInvention | Improvements in or relating to novel steroids and the manufacture thereof |
| abstract | 1,147,202. 7α-Methyl androstane derivatives. UPJOHN CO. 6 April, 1966 [7 April, 1965], No. 15369/66. Heading C2U. The invention comprises of compounds of the formula wherein R 1 and R 2 are hydrogen or methyl, Z<SP>1</SP> is lower alkyl of from one to twelve carbon atoms, inclusive, or the lower acyl radical of a hydrocarbon carboxylic acid containing from one to twelve carbon atoms, inclusive, and M is | -C = O; and processes whereby (1) a #<SP>4</SP>-3- ketone of formula wherein R 1 , R 2 and M are as defined above, is reacted with an anhydride, chloride or bromide of an organic carboxylic acid in the presence of an acid catalyst to give the corresponding 3- acyloxy-3,5-diene compound, (2) #<SP>4,8</SP>-3-ketones of formula wherein R 1 , R 2 , A, Z and M are as defined above; are reacted with an excess of Grignard reagent in the presence of a catalyst. An anhydride of a hydrocarbon carboxylic acid in a solvent is added to give 3,5-androstadiene-3- monoacylate of formula wherein R 1 , R 2 , A, Z and M are as defined above and Ac is the acyl radical of a hydrocarbon carboxylic acid containing from one to twelve carbon atoms, inclusive. The whole reaction being carried out with the exclusion of oxygen. (3) The #<SP>4</SP>-3-keto compounds of formula wherein R 1 , R 2 and M are as defined above; are converted to their corresponding 3-enolethers by known methods, e.g. by reaction with trialkyl orthoformate in the presence of a catalyst. Pharmaceutical compositions comprising of the above compounds having erythroporetic, anti-fertility, anti-androgenic and anti-estrogenic activities are administered orally or parenterally. |
| priorityDate | 1965-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.